Article

An mRNA vaccine candidate for the SARS-CoV-2 Omicron variant

2022-02-07

Abstract excerpt

The newly emerged Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains more than 30 mutations on the spike protein, 15 of which are located within the receptor binding domain (RBD). Consequently, Omicron is able to extensively escape existing neutralizing antibodies and may therefore compromise the efficacy of current vaccines based on the original strain, highlighting the impor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e38f4f73-6ee3-53e2-a659-f0a77f0e421a
DOI: 10.1101/2022.02.07.479348

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An mRNA vaccine candidate for the SARS-CoV-2 Omicron variantDOI 10.1101/2022.02.07.479348Read

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2Semantic proximity Read

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variantSemantic proximity Read

Omicron-specific mRNA vaccine elicits potent immune responses in mice, hamsters, and nonhuman primatesSemantic proximity Read

Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variantsSemantic proximity Read

RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.Semantic proximity Read

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantSemantic proximity Read

Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized miceSemantic proximity Read

Broadly Neutralizing Antibodies Against Omicron Variants of SARS-CoV-2 Derived from mRNA-Lipid Nanoparticle-Immunized MiceSemantic proximity Read

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantSemantic proximity Read

Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2Semantic proximity Read

Omicron: Call for updated vaccinesSemantic proximity Read

Breakthrough Infections with SARS-CoV-2 Omicron Variant Despite Booster Dose of mRNA VaccineSemantic proximity Read